DiagnaMed Enhances CERVAI Brain Health Platform Commercialization Efforts In Canada
DiagnaMed Holdings (CSE: DMED) continues to progress with the commercialization of its CERVAI Brain Health AI Platform. The platform has recently been accepted into the Hamilton Ecosystem to Accelerate and Leverage Trials of Health Innovation.
Fabio Chianelli National Research Council Of Canada Research Institute At St Hamilton Health Sciences Canacom Group Leverage Trials Of Health Innovation
Source: thedeepdive.ca